Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Kyle O. Rove

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-SRG
Phone303/724-2714

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Strine AC, Chu DI, Brockel MA, Wilcox DT, Vricella GJ, Coplen DE, Traxel EJ, Chaudhry R, VanderBrink BA, Yerkes EB, Chan YY, Burjek NE, Zee RS, Herndon CDA, Ahn JJ, Merguerian PA, Meenakshi-Sundaram B, Rensing AJ, Frimberger D, Rove KO. Feasibility of Enhanced Recovery After Surgery (ERAS) implementation in Pediatric Urology: Pilot-phase outcomes of a prospective, multi-center study. J Pediatr Urol. 2023 Dec 30. PMID: 38212167.
      View in: PubMed
    2. Goff SH, Pickett-Nairne K, Nguyen T, Rove KO, Friedman NR. The Effect of Social Vulnerability on Perioperative Tonsillectomy Outcomes in Children. Laryngoscope. 2023 Nov 16. PMID: 37971081.
      View in: PubMed
    3. Tasian GE, Dickinson K, Park G, Marchesani N, Mittal A, Cheng N, Ching CB, Chu DI, Walton R, Yonekawa K, Gluck C, Muneeruddin S, Kan KM, DeFoor W, Rove K, Forrest CB. Distinguishing characteristics of pediatric patients with primary hyperoxaluria type 1 in PEDSnet. J Pediatr Urol. 2024 02; 20(1):88.e1-88.e9. PMID: 37848358.
      View in: PubMed
    4. Ching CB, Dickinson K, Karafilidis J, Marchesani N, Mucha L, Antunes N, Razzaghi H, Utidjian L, Yonekawa K, Coplen DE, Muneeruddin S, DeFoor W, Rove KO, Forrest CB, Tasian GE. The real world experience of pediatric primary hyperoxaluria patients in the PEDSnet clinical research network. Eur J Pediatr. 2023 Sep; 182(9):4027-4036. PMID: 37392234.
      View in: PubMed
    5. Tasian GE, Maltenfort MG, Rove K, Ching CB, Ramachandra P, DeFoor B, Fernandez N, Forrest CB, Ellison JS. Ureteral Stent Placement Prior to Definitive Stone Treatment Is Associated With Higher Postoperative Emergency Department Visits and Opioid Prescriptions for Youth Having Ureteroscopy or Shock Wave Lithotripsy. J Urol. 2023 06; 209(6):1194-1201. PMID: 36812398.
      View in: PubMed
    6. Szymanski KM, Adams CM, Alkawaldeh MY, Austin PF, Bowman RM, Castillo H, Castillo J, Chu DI, Estrada CR, Fascelli M, Frimberger DC, Gargollo PC, Hamdan DG, Hecht SL, Hopson B, Husmann DA, Jacobs MA, MacNeily AE, McLeod DJ, Metcalfe PD, Meyer T, Misseri R, O'Neil J, Rensing AJ, Routh JC, Rove KO, Sawin KJ, Schlomer BJ, Shamblin I, Sherlock RL, Slobodov G, Stout J, Tanaka ST, Weiss DA, Wiener JS, Wood HM, Yerkes EB, Blount J. Causes of death among people with myelomeningocele: A multi-institutional 47-year retrospective study. J Pediatr Rehabil Med. 2023; 16(4):605-619. PMID: 38073338.
      View in: PubMed
    7. Tran WT, Boxley PJ, Wilcox DT, Vemulakonda VM, Wood D, Rove KO. Retrospective analysis of bladder perforation risk in patients after augmentation cystoplasty using an extraperitoneal approach. J Pediatr Urol. 2023 04; 19(2):192.e1-192.e8. PMID: 36585277.
      View in: PubMed
    8. Moore RP, Burjek NE, Brockel MA, Strine AC, Acks A, Boxley PJ, Chidambaran V, Vricella GJ, Chu DI, Sankaran-Raval M, Zee RS, Cladis FP, Chaudhry R, O'Reilly-Shah VN, Ahn JJ, Rove KO. Evaluating the role for regional analgesia in children with spina bifida: a retrospective observational study comparing the efficacy of regional versus systemic analgesia protocols following major urological surgery. Reg Anesth Pain Med. 2023 01; 48(1):29-36. PMID: 36167478.
      View in: PubMed
    9. Reppucci ML, Wehrli LA, Schletker J, Nolan MM, Rieck J, Fares S, Ketzer J, Rove K, Pena A, de la Torre L, Bischoff A. The effect of an enhanced recovery protocol in pediatric patients who undergo colostomy closure and Malone procedures. Pediatr Surg Int. 2022 Dec; 38(12):1701-1707. PMID: 36098796.
      View in: PubMed
    10. Rove KO, Halstead NV, Wiesen BM, Bielsky AR, Campbell JB. Randomized controlled trial of NSAID prior to cystoscopic ureteral stent removal in a pediatric population. J Pediatr Urol. 2022 Aug 06. PMID: 35987678.
      View in: PubMed
    11. Tasian G, Dickinson K, Karafilidis J, Marchesani N, Antunes N, Razzaghi H, Utidjian L, Yonekawa K, Coplen D, Muneeruddin S, DeFoor B, Rove KO, Forrest C, Ching C. Diagnostic Code-Based Screening for Identifying Children with Primary Hyperoxaluria. J Urol. 2022 10; 208(4):898-905. PMID: 35930731.
      View in: PubMed
    12. Diaz-Miron J, Ogle S, Kaizer A, Acker SN, Rove KO, Inge TH. Surgeon, patient, and caregiver perspective of pediatric surgical telemedicine in the COVID-19 pandemic era. Pediatr Surg Int. 2022 Feb; 38(2):241-248. PMID: 34550442.
      View in: PubMed
    13. Chan YY, Chu DI, Hirsch J, Kim S, Rosoklija I, Studer A, Brockel MA, Cheng EY, Raval MV, Burjek NE, Rove KO, Yerkes EB. Implementation and sustainability of an enhanced recovery pathway in pediatric bladder reconstruction: Flexibility, commitment, teamwork. J Pediatr Urol. 2021 Dec; 17(6):782-789. PMID: 34521600.
      View in: PubMed
    14. Chan YY, Rosoklija I, Meade P, Burjek NE, Raval MV, Yerkes EB, Rove KO, Chu DI. Utilization of and barriers to enhanced recovery pathway implementation in pediatric urology. J Pediatr Urol. 2021 06; 17(3):294.e1-294.e9. PMID: 33663997.
      View in: PubMed
    15. Rove KO, Strine AC, Wilcox DT, Vricella GJ, Welch TP, VanderBrink B, Chu DI, Chaudhry R, Zee RS, Brockel MA. Design and development of the Pediatric Urology Recovery After Surgery Endeavor (PURSUE) multicentre pilot and exploratory study. BMJ Open. 2020 11 23; 10(11):e039035. PMID: 33234633.
      View in: PubMed
    16. Han DS, Brockel MA, Boxley PJ, D?nmez MI, Saltzman AF, Wilcox DT, Rove KO. Enhanced recovery after surgery and anesthetic outcomes in pediatric reconstructive urologic surgery. Pediatr Surg Int. 2021 Jan; 37(1):151-159. PMID: 33161476.
      View in: PubMed
    17. Hecht S, Halstead NV, Boxley P, Brockel MA, Rove KO. Opioid prescribing patterns following implementation of Enhanced Recovery After Surgery (ERAS) protocol in pediatric patients undergoing lower tract urologic reconstruction. J Pediatr Urol. 2021 02; 17(1):84.e1-84.e8. PMID: 33229228.
      View in: PubMed
    18. Rove KO, Vemulakonda VM. Editorial Commentary. Urol Pract. 2020 Nov; 7(6):459-460. PMID: 37287164.
      View in: PubMed
    19. Derderian SC, Rove KO. Enhanced recovery after surgery among adolescents undergoing bariatric surgery. Semin Pediatr Surg. 2020 Feb; 29(1):150885. PMID: 32238290.
      View in: PubMed
    20. Ogawa S, Schlaepfer CH, Weaver J, Meenakshi-Sundaram B, Coplen D, Rove KO, Vricella GJ. Antenatal Presentation of Wilms' Tumor. Urology. 2019 Dec; 134:225-227. PMID: 31421145.
      View in: PubMed
    21. Rove KO, Brockel MA, Brindle ME, Scott MJ, Herndon CDA, Ljungqvist O, Koyle MA. Embracing change-the time for pediatric enhanced recovery after surgery is now. J Pediatr Urol. 2019 Oct; 15(5):491-493. PMID: 31109886.
      View in: PubMed
    22. Weaver J, Rove KO, Meenakshi-Sundaram B, Vricella GJ. Genetic Testing Proves Crucial in Case of Ambiguous Genitalia and Renal Masses. Urology. 2019 Jul; 129:194-196. PMID: 30914336.
      View in: PubMed
    23. Rove KO, Vricella GJ, Hershey T, Thu MH, Lugar HM, Vetter J, Marshall BA, Austin PF. Lower Urinary Tract Dysfunction and Associated Pons Volume in Patients with Wolfram Syndrome. J Urol. 2018 11; 200(5):1107-1113. PMID: 29883657.
      View in: PubMed
    24. Weaver J, Rove KO, Vricella GJ. Extra-adrenal Pheochromocytoma Associated With Segmental Renal Artery Compression and Pseudostenosis. Urology. 2018 Oct; 120:238-240. PMID: 29800631.
      View in: PubMed
    25. Ballard DH, Rove KO, Coplen DE, Chen TY, Hulett Bowling RL. Fibroepithelial polyp causing urethral obstruction: Diagnosis by cystourethrogram. Clin Imaging. 2018 Sep - Oct; 51:164-167. PMID: 29800931.
      View in: PubMed
    26. Rove KO, Edney JC, Brockel MA. Enhanced recovery after surgery in children: Promising, evidence-based multidisciplinary care. Paediatr Anaesth. 2018 06; 28(6):482-492. PMID: 29752858.
      View in: PubMed
    27. Rove KO, Brockel MA, Saltzman AF, D?nmez MI, Brodie KE, Chalmers DJ, Caldwell BT, Vemulakonda VM, Wilcox DT. Prospective study of enhanced recovery after surgery protocol in children undergoing reconstructive operations. J Pediatr Urol. 2018 06; 14(3):252.e1-252.e9. PMID: 29398586.
      View in: PubMed
    28. Rove KO, Warncke JC, Vemulakonda VM. Trends in pediatric urologic consultations in a tertiary care hospital setting. J Pediatr Urol. 2018 02; 14(1):12.e1-12.e8. PMID: 28826658.
      View in: PubMed
    29. Rove KO, Husmann DA, Wilcox DT, Vricella GJ, Higuchi TT. Systematic review of bladder cancer outcomes in patients with spina bifida. J Pediatr Urol. 2017 Oct; 13(5):456.e1-456.e9. PMID: 28687411.
      View in: PubMed
    30. Okland T, Karimkhani C, Pederson H, Boyers LN, Sawyer MD, Rove KO, Kenny MC, Steinberg S, Naghavi M, Dellavalle RP. Research prioritization of men's health and urologic diseases. Int Braz J Urol. 2017 Mar-Apr; 43(2):289-303. PMID: 28128909.
      View in: PubMed
    31. Rove KO, Maroni PD, Cost CR, Fairclough DL, Giannarini G, Harris AK, Schultz KA, Cost NG. Pathologic Risk Factors for Metastatic Disease in Postpubertal Patients With Clinical Stage I Testicular Stromal Tumors. Urology. 2016 11; 97:138-144. PMID: 27538802.
      View in: PubMed
    32. Rove KO, Higuchi TT. Monitoring and malignancy concerns in patients with congenital bladder anomalies. Curr Opin Urol. 2016 07; 26(4):344-50. PMID: 27139193.
      View in: PubMed
    33. Rove KO, Maroni PD, Cost CR, Fairclough DL, Giannarini G, Harris AK, Schultz KA, Cost NG. Pathologic Risk Factors in Pediatric and Adolescent Patients With Clinical Stage I Testicular Stromal Tumors. J Pediatr Hematol Oncol. 2015 Nov; 37(8):e441-6. PMID: 26479987.
      View in: PubMed
    34. Chalmers DJ, Rove KO, Wiedel CA, Tong S, Siparsky GL, Wilcox DT. Clean intermittent catheterization as an initial management strategy provides for adequate preservation of renal function in newborns with persistent cloaca. J Pediatr Urol. 2015 Aug; 11(4):211.e1-4. PMID: 26187141.
      View in: PubMed
    35. Crawford ED, Rove KO, Stone NN, Lucia MS, Barqawi AB, La Rosa FG. Moving Forward the State of the Art in Prostate Cancer Treatment: Targeted Focal Therapy. Urol Pract. 2014 Sep; 1(3):156-164. PMID: 37537812.
      View in: PubMed
    36. Rove KO, Crawford ED, Perachino M, Morote J, Klotz L, Lange PH, Andriole GL, Matsumoto AM, Taneja SS, Eisenberger MA, Reis LO. Maximal testosterone suppression in prostate cancer--free vs total testosterone. Urology. 2014 Jun; 83(6):1217-22. PMID: 24713136.
      View in: PubMed
    37. Rove KO, Crawford ED. Traditional androgen ablation approaches to advanced prostate cancer: new insights. Can J Urol. 2014 Apr; 21(2 Supp 1):14-21. PMID: 24775719.
      View in: PubMed
    38. Rove KO, Crawford ED. Androgen annihilation as a new therapeutic paradigm in advanced prostate cancer. Curr Opin Urol. 2013 May; 23(3):208-13. PMID: 23492838.
      View in: PubMed
    39. Crawford ED, Rove KO. Advanced prostate cancer: therapeutic sequencing, outcomes, and cost implications. Am J Manag Care. 2012 12; 18(5 Spec No.):SP250-3. PMID: 23301715.
      View in: PubMed
    40. Crawford ED, Rove KO, Barqawi AB, Maroni PD, Werahera PN, Baer CA, Koul HK, Rove CA, Lucia MS, La Rosa FG. Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens. Prostate. 2013 May; 73(7):778-87. PMID: 23169245.
      View in: PubMed
    41. Crawford ED, Rove KO, Trabulsi EJ, Qian J, Drewnowska KP, Kaminetsky JC, Huisman TK, Bilowus ML, Freedman SJ, Glover WL, Bostwick DG. Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 cases. J Urol. 2012 Nov; 188(5):1726-31. PMID: 22998901.
      View in: PubMed
    42. Oberley-Deegan RE, Steffan JJ, Rove KO, Pate KM, Weaver MW, Spasojevic I, Frederick B, Raben D, Meacham RB, Crapo JD, Koul HK. The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiation. PLoS One. 2012; 7(9):e44178. PMID: 22984473.
      View in: PubMed
    43. Rove KO, Debruyne FM, Djavan B, Gomella LG, Koul HK, Lucia MS, Petrylak DP, Shore ND, Stone NN, Crawford ED. Role of testosterone in managing advanced prostate cancer. Urology. 2012 Oct; 80(4):754-62. PMID: 22795376.
      View in: PubMed
    44. Rove KO, Crawford ED. Editorial comment. J Urol. 2012 Jun; 187(6):2049; discussion 2050. PMID: 22498224.
      View in: PubMed
    45. Rove KO, Crawford ED. Evolution of treatment options for patients with CRPC and bone metastases: bone-targeted agents that go beyond palliation of symptoms to improve overall survival. Oncology (Williston Park). 2011 Dec; 25(14):1362-70, 1375-81, 1387. PMID: 22329188.
      View in: PubMed
    46. Rove KO, Crawford ED. Randomized controlled screening trials for prostate cancer using prostate-specific antigen: a tale of contrasts. World J Urol. 2012 Apr; 30(2):137-42. PMID: 22116599.
      View in: PubMed
    47. Deb AA, Wilson SS, Rove KO, Kumar B, Koul S, Lim DD, Meacham RB, Koul HK. Potentiation of mitomycin C tumoricidal activity for transitional cell carcinoma by histone deacetylase inhibitors in vitro. J Urol. 2011 Dec; 186(6):2426-33. PMID: 22019171.
      View in: PubMed
    48. Crawford ED, Moul JW, Rove KO, Pettaway CA, Lamerato LE, Hughes A. Prostate-specific antigen 1.5-4.0 ng/mL: a diagnostic challenge and danger zone. BJU Int. 2011 Dec; 108(11):1743-9. PMID: 21711431.
      View in: PubMed
    49. Barqawi AB, Rove KO, Gholizadeh S, O'Donnell CI, Koul H, Crawford ED. The role of 3-dimensional mapping biopsy in decision making for treatment of apparent early stage prostate cancer. J Urol. 2011 Jul; 186(1):80-5. PMID: 21571335.
      View in: PubMed
    50. Wohlauer MV, Rove KO, Pshak TJ, Raeburn CD, Moore EE, Chenoweth C, Srivastava A, Pell J, Meacham RB, Nehler MR. The computerized rounding report: implementation of a model system to support transitions of care. J Surg Res. 2012 Jan; 172(1):11-7. PMID: 21777923.
      View in: PubMed
    51. Rove KO, Crawford ED. Dutasteride: novel milestones in prostate cancer chemoprevention. Drugs Today (Barc). 2011 Feb; 47(2):135-44. PMID: 21431101.
      View in: PubMed
    52. Koul H, Huh JS, Rove KO, Crompton L, Koul S, Meacham RB, Kim FJ. Molecular aspects of renal cell carcinoma: a review. Am J Cancer Res. 2011; 1(2):240-254. PMID: 21969126.
      View in: PubMed
    53. Rove KO, Flaig TW. A renaissance in the medical treatment of advanced prostate cancer. Oncology (Williston Park). 2010 Dec; 24(14):1308-13, 1318. PMID: 21294475.
      View in: PubMed
    54. Crawford ED, Rove KO. Incomplete testosterone suppression in prostate cancer. N Engl J Med. 2010 Nov 11; 363(20):1976. PMID: 21067409.
      View in: PubMed
    55. Rove KO, Sullivan KF, Crawford ED. High-intensity focused ultrasound: ready for primetime. Urol Clin North Am. 2010 Feb; 37(1):27-35, Table of Contents. PMID: 20152517.
      View in: PubMed
    56. Rove KO, Crawford ED. Metastatic cancer in solid tumors and clinical outcome: skeletal-related events. Oncology (Williston Park). 2009 Dec; 23(14 Suppl 5):21-7. PMID: 20128325.
      View in: PubMed
    Rove's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (264) concept(s)
    _
    Co-Authors Expand Description
    See all (30) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)